We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ACA:EURONEXT PARISCredit Agricole SA analysis

Data as of Sep 20, 2026 - not real-time

Latest price
$145.84
Risk: low
3/10Low risk

Summary

Arcosa, Inc. is priced at $145.84 and its moving averages line up in bullish order, the shorter sitting above the longer. RSI sits at 63.5, which reads as approaching overbought, and MACD momentum is bearish. Watch $144.90 as support and $145.84 as the nearer resistance level.
Multiples put this in fair territory: 32.6 times earnings against the sector's 27.6. The 0.14% dividend yield looks covered by current payout levels.
The composite risk read is 3/10, putting it in low territory. With 30-day volatility of 2.5%, a beta of 1.00 and a maximum drawdown of 21.4%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons diverge: buy near-term but hold on a long view, at 3/10 conviction over the longer horizon.

Top market events

  • DALLAS-- BUSINESS WIRE --Arcosa, Inc. NYSE: ACA "Arcosa" or the "Company" , a provider of infrastructure-related...
  • ACA stock is in focus after Arcosa Inc. declared a new quarterly cash dividend of 0.05 dollars per s
  • ACA stock reflects Arcosa's role in North American infrastructure, with recent quarterly figures and

Market outlook

Short term

< 1 year

Positive

Model confidence4/104 out of 10

Key factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 125.30
  • MACD momentum is negative

Medium term

1–3 years

Neutral

Model confidence3/103 out of 10

Key factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 32.6 versus sector average of 27.6
  • Trading above the 200-day average of 125.30

Long term

> 3 years

Neutral

Model confidence3/103 out of 10

Key factors

  • P/E of 32.6 versus sector average of 27.6
  • Profit margin of 16.8% is healthy
  • Dividend yield of 0.14%

Key metrics

Financial health

Revenue Growth1.70%
Profit Margin16.84%
P/E Ratio32.6
ROE8.03%
ROA3.88%
Debt/Equity50.58
P/B Ratio2.4
Op. Cash Flow$341.3M
Free Cash Flow$60.3M
Industry P/E27.6

Technical analysis

TrendBullish
RSI63.5
Support$144.90
Resistance$145.84
MA 20$145.33
MA 50$145.17
MA 200$125.30
MACDBearish
VolumeIncreasing
Fear & Greed Index94.98

Valuation

Target Price$146.67
Upside/Downside0.57%
GradeFair
TypeBlend
Dividend Yield0.14%

Risk assessment

Beta1.00
Volatility2.50%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.